{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:45:31Z","timestamp":1778658331666,"version":"3.51.4"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,2,11]],"date-time":"2002-02-11T00:00:00Z","timestamp":1013385600000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> Prospective studies in children with B\u2010precursor acute lymphoblastic leukaemia (ALL) have shown that polymerase chain reaction (PCR)\u2010based detection of minimal residual disease (MRD) using immunoglobin (<jats:italic>Ig<\/jats:italic>) and T\u2010cell receptor (<jats:italic>TCR<\/jats:italic>) gene rearrangements as targets can be used to identify patients with a high relapse risk. The disadvantage of this approach is that for each patient preferably two different targets have to be identified. The t(12;21)(p13;q22) with the <jats:italic>TEL\u2010AML1<\/jats:italic> fusion gene is present in approximately 25% of children with B\u2010precursor ALL. In these patients, sensitive reverse transcription (RT)\u2010PCR analysis of the <jats:italic>TEL\u2010AML1<\/jats:italic> fusion transcript might be a more simple and less laborious alternative approach. However, it is unknown how stable the mRNA is and whether the number of transcripts per leukaemic cell remains constant during follow\u2010up. We investigated whether the MRD results obtained using RT\u2010PCR of <jats:italic>TEL\u2010AML1<\/jats:italic> transcripts correlated with the clinically validated genomic PCR for <jats:italic>Ig<\/jats:italic> and <jats:italic>TCR<\/jats:italic> gene rearrangements. Therefore, we used real\u2010time quantitative (RQ)\u2010PCR analysis for both types of targets and assessed the MRD levels in 36 follow\u2010up bone marrow samples (obtained during the first 1\u00b75\u2003years after diagnosis) from 13 patients with B\u2010precursor ALL. In 34\/36 bone marrow samples the <jats:italic>Ig\/TCR<\/jats:italic> RQ\u2010PCR and <jats:italic>TEL\u2010AML1<\/jats:italic> RQ\u2010PCR revealed equal levels of MRD and these results had a strong correlation (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b70001, <jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2003=\u20030\u00b784). Therefore, we conclude that the <jats:italic>TEL\u2010AML1<\/jats:italic> RQ\u2010PCR can, in principle, replace <jats:italic>Ig\/TCR<\/jats:italic> RQ\u2010PCR in B\u2010precursor ALL with t(12;21).<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03228.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:41:35Z","timestamp":1047364895000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The <i>TEL\u2010AML1<\/i> real\u2010time quantitative polymerase chain reaction (PCR) might replace the antigen receptor\u2010based genomic PCR in clinical minimal residual disease studies \u2028in children with acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"116","author":[{"given":"V.","family":"De Haas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. B.","family":"Breunis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Dee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. J. H. M.","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Kroes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. R.","family":"Van Wering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J. M.","family":"Van Dongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Van Den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Van Der Schoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,2,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1988.tb02993.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950250106"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.12.5251.bloodjournal87125251"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90988-1"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1182\/blood.V83.7.1892.1892","article-title":"Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T\u2010cell receptor genes","volume":"83","author":"Cave H.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390904"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(95)80166-9"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1997.1141"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)10295-1"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04058-6"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401592"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.11.4917"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V92.3.952","article-title":"Clonal diversity of Ig and T\u2010cell\u2010receptor gene rearrangements identifies a subset of childhood B\u2010precursor acute lymphoblastic leukemia with increased risk of relapse","volume":"92","author":"Green E.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood.V96.4.1619","article-title":"Accurate quantification of minimal residual disease at day 15, by real\u2010time quantitative polymerase chain reaction identifies also patients with B\u2010precursor acute lymphoblastic leukemia at high risk for relapse","volume":"96","author":"De Haas V.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02434.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401970"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1792996.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.11.4252.bloodjournal88114252"},{"key":"e_1_2_6_20_1","unstructured":"Medical Research Council Centre for Protein Engineering(1997) VBase the database of human antibody genes. WWW document. URL.http:\/\/www.mrc\u2010cpe.cam.ac.uk\/imt\u2010doc."},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199912)26:4<355::AID-GCC10>3.3.CO;2-V"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401246"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401245"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1182\/blood.V86.11.4263.bloodjournal86114263","article-title":"High frequency of t(12; 21) in childhood B\u2010lineage acute lymphoblastic leukemia","volume":"86","author":"Romana S.P.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_25_1","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL\u2010BFM 90. German\u2010Austrian\u2010Swiss ALL\u2010BFM Study Group","volume":"95","author":"Schrappe M.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_26_1","first-page":"1985","article-title":"TEL\/AML1 fusion resulting from a cryptic t(12; 21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis","volume":"9","author":"Shurtleff S.A.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_27_1","first-page":"1726","article-title":"Prolonged persistence of PCR\u2010detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B\u2010 precursor acute lymphoblastic leukemia","volume":"9","author":"Steenbergen E.J.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_28_1","first-page":"216","article-title":"IgH\/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B\u2010 precursor ALL","volume":"9","author":"Steenbergen E.J.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_29_1","first-page":"1471","article-title":"Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B\u2010precursor acute lymphoblastic leukemia after engraftment in SCID mice","volume":"10","author":"Steenbergen E.J.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199805000-00002"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V95.3.815.003k30_815_819","article-title":"Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8; 21) can identify patients in durable remission and predict clinical relapse","volume":"95","author":"Tobal K.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb55804.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.3.911"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401451"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401801"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.12.1879"},{"key":"e_1_2_6_37_1","first-page":"63","article-title":"Aconsensus strategy to quantitate malignant cells in Myelomapatients validated in a multicentre study","volume":"96","author":"Willems P.M.W.","year":"2000","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03228.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03228.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03228.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:17:13Z","timestamp":1697415433000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03228.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03228.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03228.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"2002-02-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}